ON DEMAND WEBINAR
Metabolomics in Multiomics Research: 5 Key Case Studies of Multiomics Research Driving Novel Insight Discovery
Multiomics research is crucial for understanding complex biological systems at a comprehensive level. By integrating data from genomics, transcriptomics, proteomics, metabolomics, and other omics disciplines, researchers can unravel intricate interactions and pathways within cells and organisms.
By helping researchers to more easily integrate multiomics data, multiomics studies can accelerate the path to novel actionable insights, identifying biomarkers and pathway associations that show the relationships and causalities of genetics, environment, and lifestyle on biological systems.
In this webinar, Brian Keppler, Ph.D., Director of Discovery and Translational Sciences at Metabolon, explores five publications that highlight the utility of multiomics research. These publications span different omic technologies and research applications which demonstrates the importance of multiomic insights.
About Metabolomics
Metabolomics, the study of small molecules, is integral to multiomics research. Analyzing metabolites complements genomics, proteomics, and transcriptomics, providing a snapshot of cellular function and metabolic changes. Combining metabolomics with other omics data enhances understanding of biological systems and adds additional insights into the phenotype.
You will learn:
- How metabolomic data can be combined with genomics, proteomic, and microbiome analysis to produce novel insights into disease
- Considerations for designing multiomic studies
- Benefits of targeted and untargeted metabolomics approaches
Program
- Genome-wide association studies of metabolites in Finnish men identify disease-relevant loci
- Multi-omics data integration reveals metabolome as the top predictor of the cervicovaginal microenvironment
- Multi-omics of gut microbiome-host interactions in short- and long-term myalgic encephalomyelitis/chronic fatigue syndrome patients
- Multiomics profiles of the intestinal microbiome in irritable bowel syndrome and its bowel habit subtypes
- Molecular signatures of post-traumatic stress disorder in war-zone-exposed veteran and active-duty soldiers
Speakers
Brian Keppler, Ph.D.
Director of Discovery and Translational Sciences at Metabolon
Dr. Brian Keppler is the Director of Metabolon’s Commercial Discovery and Translational Sciences team and serves as the lead scientific liaison for global business opportunities with pharmaceutical, biotechnology, and applied markets companies. Brian has been with Metabolon since 2011 and manages company efforts toward illuminating novel biological insights and supporting meaningful decision-making to accelerate research and development and advance client success. He received his Ph.D. in Pharmaceutical Sciences from the University of North Carolina at Chapel Hill and completed his postdoctoral training at the National Institute of Environmental Health Sciences in Research Triangle Park, NC.
Heino Heyman, Ph.D.
Global Field Metabolomics Manager at Metabolon
Dr. Heino M. Heyman is a seasoned Metabolomics professional with an accomplished career spanning over a decade. He embarked on his journey in 2010, utilizing metabolomics to expedite the discovery of active constituents in natural products and to enhance the understanding of resilient crops. In 2015, he joined the Integrative Omics team at Pacific Northwest National Lab, WA, where he broadened the application of metabolomics across diverse sectors, including human, microbial, plant, and soil metabolomics.
Following his postdoctoral studies, he transitioned to the industry, joining Bruker Scientific as a Metabolomics Applications Specialist. He excelled in promoting and demonstrating solutions using sophisticated ion-mobility mass spectrometry instrumentation. In 2020, he joined Metabolon, deepening his involvement in translational science informed by metabolomics. Since 2023, he has been leading a team of metabolomics specialists as Global Metabolomics Application Lead, elevating the metabolomics experience for clients at Metabolon.
